Clinical application of multi-mode analgesia in the treatment of hepatic echinococcosis in accelerated rehabilitation surger

Application of transversus abdominis fascia plane block multimodal analgesia in hepatic hydatidosis patients with enhanced recovery after surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100053689

Enrollment

Unknown

Registered

2021-11-27

Start date

2021-11-21

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic echinococcosis

Interventions

experimental group:Standardized rapid recovery management (ERAS) + transverse abdominal fascia plane block (TAP) + intravenous analgesia pump (PCIA) + tramadol (Tramadol) multimodal analgesia treatmen

Control group:Conventional analgesic

Eligibility

Sex/Gender

All

Age

14 Years to 75 Years

Inclusion criteria

Inclusion criteria: The patients with hepatic hydatidosis who received surgical treatment. The patients with extrahepatic echinococcosis and complicated hepatic echinococcosis were excluded.

Exclusion criteria

Exclusion criteria: Patients with complicated hepatic echinococcosis and advanced complex hepatic hydatid disease.

Design outcomes

Primary

Measure	Time frame
postoperative pain score;postoperative tramadol intramuscular injection dosage;Get out of bed time;start eating time;exhaust time;pulmonary infection;electrolyte disturbance;phlebothrombosis;	—

Countries

China

Contacts

Public ContactZhang Zeling

The People's Hospital of Aba Tibetan and Qiang Autonomous Prefecture

13558580027@139.com+86 13558580027

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026